Mycoplasma Testing Market by Product & Services (Kits & Reagent and Instruments), Technique (PCR, ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and Virus Testing), End User (Pharmaceutical Companies and Cell Banks) - Global Forecast to 2022

Publisher Name :
Date: 14-Jun-2017
No. of pages: 156
Inquire Before Buying

The global mycoplasma testing market is expected to reach USD 943.4 million by 2022, at a CAGR of 12.5% from 2017 to 2022. The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination. On the other hand, the growth of this market is hindered to some extent due to the stringent regulatory framework& time-consuming approval processes and the high degree of consolidation which acts as an entry barrier for new companies.

Mycoplasma testing market to register the highest CAGR during the forecast period

On the basis of products, the mycoplasma testing market is segmented intokits & reagents, instruments, and services. The kits & reagents segment is expected to grow at a higher rate during the forecast period. Thisis attributed to the frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques.

Pharmaceutical and biotechnology companies to dominate the mycoplasma testing market during the forecast period

Based on end users, the mycoplasma testingmarket is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users. In 2017, pharmaceutical and biotechnology companies segment is expected to commandthe largest share and is estimated to grow at the fastest rate as compared to the other segments. This can be attributed to the increasing R&D investments in the pharmaceutical industry.

Asia is estimated to be the fastest growing regional segment in the global mycoplasma testing market during the forecast period

Geographically, the mycoplasma testing market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asia region is estimated to grow at the fastest rate which canbe attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

The primary interviews conducted for this report can be categorized as follows:


  • By Company Type - Tier 1 – 37%, Tier 2 – 47%, Tier 3-16%

  • By Designation – C level – 46%, Director level – 36%, Others – 18%

  • By Region – North America - 26%, Europe – 30%, APAC – 22%, South America –13% and Middle East & Africa: 9%


The key players in the market are Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), InvivoGen (U.S.), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd., WuXi AppTec (U.S.), Norgen Biotek Corp. (Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A (Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories (U.S.), GeneCopoeia, Inc. (U.S.), GenBio (Canada), Hylabs (Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (U.S.), Sartorius AG (Germany), Savyon Diagnostics (Israel), and Scien Cell Research Laboratories, Inc. (Canada).

Study Coverage:

The report analyses the mycoplasma testing market by product, technique, application, end user, and region. Apart from comprehensive geographic &product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Key benefits of buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios of the top players in the mycoplasma testing market

  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the mycoplasma testing market

  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the mycoplasma testing market

  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various mycoplasma testing products across geographies

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the mycoplasma testing market

Mycoplasma Testing Market by Product & Services (Kits & Reagent and Instruments), Technique (PCR, ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and Virus Testing), End User (Pharmaceutical Companies and Cell Banks) - Global Forecast to 2022

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown & Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Mycoplasma Testing Market: Premium Insights
4.1 Mycoplasma Testing: Market Overview
4.2 Geographic Analysis: By Application (2017)
4.3 By Product and Service, 2017–2022
4.4 Geographical Snapshot of the global market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Growth and Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.2 Strong Trend of R&D Investments in Life Sciences
5.2.1.3 Cell Culture Contamination—A Major Concern for Laboratories
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Pharmaceutical and Biotechnology Companies
5.2.3 Opportunity
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.4 Challenge
5.2.4.1 Shortage of Skilled Professionals

6 Mycoplasma Testing Market, By Product & Service
6.1 Introduction
6.2 Kits & Reagents
6.2.1 PCR Assays
6.2.2 Nucleic Acid Detection Kits
6.2.3 Elimination Kits & Reagents
6.2.4 Stains
6.2.5 Standards & Controls
6.2.6 Other Kits & Reagents
6.3 Instruments
6.4 Services

7 Mycoplasma Testing Market, By Technique
7.1 Introduction
7.2 PCR
7.3 Elisa
7.4 Direct Assays
7.5 Indirect Assays
7.6 Dna Staining
7.7 Microbial Culture Techniques
7.8 Enzymatic Methods

8 Mycoplasma Testing Market, By Application
8.1 Introduction
8.2 Cell Line Testing
8.3 Virus Testing
8.4 End-Of-Production Cell Testing
8.5 Other Applications

9 Mycoplasma Testing Market, By End User
9.1 Introduction
9.2 Pharmaceutical and Biotechnology Companies
9.3 Contract Research Organizations
9.4 Academic Research Institutes
9.5 Cell Banks
9.6 Other End Users

10 Geographic Analysis
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Introduction
11.2 Vendor Dive Overview
11.2.1 Vanguards
11.2.2 Innovators
11.2.3 Dynamic
11.2.4 Emerging
11.3 Competitive Benchmarking
11.3.1 Analysis of Product Portfolio of Major Players in Mycoplasma Teting Market (25 Players)
11.3.2 Business Strategies Adopted By Major Players in the Mycoplasma Testing Market(25 Players)

*Top 25 Companies Analyzed for This Studies are - Charles River Laboratories International, Inc.(U.S.), Merck KGaA (Germany),Roche Diagnostics ( Switzerland), Lonza Group Ltd. (Switzerland), SGS S.A. (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.),Invivogen (U.S.), Promo Cell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd, Wuxi Apptec.(U.S.), Norgen Biotek Corp.(Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A.(Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories(U.S.), Genecopoeia Inc.(U.S.), Genbio(Canada), Hylabs(Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Sartorius AG (Germany), Savyon Diagnostics(Israel), Sciencell Research Laboratories, Inc.(Canada)

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Charles River Laboratories International, Inc.
12.2 Merck KGaA
12.3 Lonza Group Ltd.
12.4 Roche Diagnostics (Division of F. Hoffman-LA Roche Ltd.)
12.5 SGS S.A.
12.6 Thermo Fisher Scientific Inc.
12.7 American Type Culture Collection
12.8 Biounique Testing Laboratories Inc.
12.9 Invivogen
12.10 Promocell GmbH
12.11 Biological Industries Israel Beit Haemek Ltd.
12.12 Wuxi Apptec
12.13 Norgen Biotek Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Industry Insights
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables

Table 1 Mycoplasma Testing: Market Snapshot
Table 2 Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 3 Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022(USD Million)
Table 4 Mycoplasma Testing Kits & Reagents Market Size, By Region, 2015–2022 (USD Million)
Table 5 PCR Assays Market Size, By Region, 2015–2022 (USD Million)
Table 6 Nucleic Acid Detection Kits Market Size, By Region, 2015–2022 (USD Million)
Table 7 Elimination Kits & Reagents Market Size, By Region, 2015–2022 (USD Million)
Table 8 Mycoplasma Testing Stains Market Size, By Region, 2015–2022 (USD Million)
Table 9 Standards & Controls Market Size, By Region, 2015–2022 (USD Million)
Table 10 Other Kits & Reagents Market Size, By Region, 2015–2022 (USD Million)
Table 11 Mycoplasma Testing Instruments Market Size, By Region, 2015–2022 (USD Million)
Table 12 Mycoplasma Testing Services Market Size, By Region, 2015–2022 (USD Million)
Table 13 Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 14 Market Size for PCR, By Region, 2015–2022 (USD Million)
Table 15 Elisa Method Market Size, By Region, 2015–2022 (USD Million)
Table 16 Direct Assays Market Size, By Region, 2015–2022 (USD Million)
Table 17 Indirect Assays Market Size, By Region, 2015–2022 (USD Million)
Table 18 Dna Staining Market Size, By Region, 2015–2022 (USD Million)
Table 19 Microbial Culture Techniques Market Size, By Region, 2015- 2022 (USD Million)
Table 20 Enzymatic Methods Market Size, By Region, 2015–2022 (USD Million)
Table 21 Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 22 Market Size for Cell Line Testing, By Region, 2015–2022 (USD Million)
Table 23 Market Size for Virus Testing, By Region, 2015–2022 (USD Million)
Table 24 Market Size for End-Of-Production Cell Testing, By Region, 2015–2022 (USD Million)
Table 25 Other Mycoplasma Testing Applications Market Size, By Region, 2015–2022 (USD Million)
Table 26 Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 27 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 28 Market Size for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 29 Market Size for Academic Research Institutes, By Region, 2015–2022 (USD Million)
Table 30 Market Size for Cell Banks, By Region, 2015–2022 (USD Million)
Table 31 Mycoplasma Testing Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 32 Market Size, By Region, 2015–2022 (USD Million)
Table 33 North America: Mycoplasma Testing Market Size, By Country, 2015–2022 (USD Million)
Table 34 North America: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 35 North America: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 36 North America: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 37 North America: Market Size, By Application, 2015–2022 (USD Million)
Table 38 North America: Market Size, By End User, 2015–2022 (USD Million)
Table 39 U.S.: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 40 U.S.: Market Size, By Technique, 2015–2022 (USD Million)
Table 41 U.S.: Market Size, By Application, 2015–2022 (USD Million)
Table 42 U.S.: Market Size, By End User, 2015–2022 (USD Million)
Table 43 Canada: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 44 Canada: Market Size, By Technique, 2015–2022 (USD Million)
Table 45 Canada: Market Size, By Application, 2015–2022 (USD Million)
Table 46 Canada: Market Size, By End User, 2015–2022 (USD Million)
Table 47 Europe: Mycoplasma Testing Market Size, By Country, 2015–2022 (USD Million)
Table 48 Europe: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 49 Europe: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 50 Europe: Market Size, By Technique, 2015–2022 (USD Million)
Table 51 Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 52 Europe: Market Size, By End User, 2015–2022 (USD Million)
Table 53 Germany: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 54 U.K.: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 55 France: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 56 Italy: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 57 Spain: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 58 RoE: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 59 Asia: Mycoplasma Testing Market Size, By Country, 2015–2022 (USD Million)
Table 60 Asia: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 61 Asia: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 62 Asia: Market Size, By Technique, 2015–2022 (USD Million)
Table 63 Asia: Market Size, By Application, 2015–2022 (USD Million)
Table 64 Asia: Market Size, By End User, 2015–2022 (USD Million)
Table 65 China: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 66 Japan: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 67 India: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 68 RoA: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 69 RoW: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 70 RoW: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 71 RoW: Market Size, By Technique, 2015–2022 (USD Million)
Table 72 RoW: Market Size, By Application, 2015–2022 (USD Million)
Table 73 RoW: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)

List of Figures

Figure 1 Global Mycoplasma Testing Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product and Service, 2017 vs 2022 (USD Million)
Figure 8 Mycoplasma Testing Kits and Reagents Market Size, By Type, 2017 vs 2022 (USD Million)
Figure 9 Mycoplasma Testing Market Size, By Technique, 2017 vs 2022 (USD Million)
Figure 10 Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 11 Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 12 Market Size, By Region, 2017 vs 2022 (USD Million)
Figure 13 Growing Pharmaceutical and Biotechnological Industries—Major Factor Driving Market Growth
Figure 14 Cell Line Testing Segment to Command the Largest Market Share in 2017
Figure 15 Services Segment to Register the Highest CAGR During the Forecast Period
Figure 16 Asia to Register the Highest CAGR Between 2017 & 2022
Figure 17 Mycoplasma Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Kits & Reagents is Expected to Command the Largest Share of the Market in 2017
Figure 19 Global Market, By Technique
Figure 20 Cell Line Testing Will Be the Fastest-Growing Application Segment Durng Forecast Period
Figure 21 Pharmaceutical & Biotechnology Companies Segment to Dominate the Market in 2017
Figure 22 Asia to Register the Highest CAGR During the Forecast Period
Figure 23 U.S. to Dominate the North American Market in 2022
Figure 24 North America: Mycoplasma Testing Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Germany to Register the Highest CAGR in the European Market During the Forecast Period
Figure 27 China Will Continue to Dominate the Asian Market in 2022
Figure 28 Asia: Mycoplasma Testing Market Snapshot
Figure 29 RoW: Mycoplasma Testing Market Snapshot
Figure 30 Dive Chart
Figure 31 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 32 Merck KGaA: Company Snapshot (2016)
Figure 33 Lonza Group Ltd.: Company Snapshot (2016)
Figure 34 F. Hoffmann-LA Roche Ltd.: Company Snapshot (2016)
Figure 35 SGS S.A.: Company Snapshot (2016)
Figure 36 Thermo Fisher Scientific Inc.: Company Snapshot (2016)

  • Global Electrophoresis Market Research Report 2017
    Published: 21-Jul-2017        Price: US 2900 Onwards        Pages: 120
    In this report, the global Electrophoresis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Electrophoresis in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Jap......
  • Global Digital PCR Market Research Report 2017
    Published: 20-Jul-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Digital PCR market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Digital PCR in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Cell-based Assays Market Research Report 2017
    Published: 20-Jul-2017        Price: US 2900 Onwards        Pages: 129
    In this report, the global Cell-based Assays market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cell-based Assays in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China -......
  • Global DNA Forensic Market Research Report 2017
    Published: 20-Jul-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global DNA Forensic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of DNA Forensic in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Microbial Identification Sales Market Report 2017
    Published: 20-Jul-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the global Microbial Identification market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Microbial Identification for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Biopreservation Market 2017-2021
    Published: 19-Jul-2017        Price: US 3500 Onwards        Pages: 81
    Bio preservation is a process that uses effective storage techniques to preserve the indigenous functionality and integrity of cells, tissues, and organs at different temperatures for an extended period. Earlier, in the field of tissue engineering, cell and tissue transplantation, and genetic engineering, and preserving of engineered cells and tissues with functional viability in an external environment is a major challenge. The analysts forecast global bio preservation market to grow......
  • Competent Cells Market by Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - Global Forecast to 2022
    Published: 19-Jul-2017        Price: US 5650 Onwards        Pages: 159
    The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restrain......
  • Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2017
    Published: 18-Jul-2017        Price: US 3500 Onwards        Pages: 37
    Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Rho-Associated Protein Kinase 1 (ROCK1) is a protein serine/threonine kinase. It is a key regulator of ......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2017
    Published: 18-Jul-2017        Price: US 3500 Onwards        Pages: 77
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Survival Motor Neuron Protein - Pipeline Review, H2 2017'; Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs